Anti-asthmatic mir-224-5p inhibits the fhl1/mapk pathway to repress airway smooth muscle cell proliferation in a murine model of asthma-like airway inflammation

HIGHLIGHTS

• who: Zhifang Zhuang from the This study was approved by the Institutional Animal Care and Use Committee of the Wujin Hospital Affiliated with Jiangsu University, and carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health have published the research: Anti-asthmatic miR-224-5p inhibits the FHL1/MAPK pathway to repress airway smooth muscle cell proliferation in a murine model of asthma-like airway inflammation, in the Journal: (JOURNAL)
• what: Given the aforementioned findings, the authors performed . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.